Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 2
1997 3
2002 2
2003 4
2004 6
2005 8
2006 6
2007 2
2009 4
2010 4
2011 2
2012 5
2013 5
2014 5
2015 7
2016 6
2017 4
2018 2
2019 4
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

73 results
Results by year
Filters applied: . Clear all
Page 1
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis.
Adams D, Gonzalez-Duarte A, O'Riordan WD, Yang CC, Ueda M, Kristen AV, Tournev I, Schmidt HH, Coelho T, Berk JL, Lin KP, Vita G, Attarian S, Planté-Bordeneuve V, Mezei MM, Campistol JM, Buades J, Brannagan TH 3rd, Kim BJ, Oh J, Parman Y, Sekijima Y, Hawkins PN, Solomon SD, Polydefkis M, Dyck PJ, Gandhi PJ, Goyal S, Chen J, Strahs AL, Nochur SV, Sweetser MT, Garg PP, Vaishnaw AK, Gollob JA, Suhr OB. Adams D, et al. Among authors: Brannagan TH. N Engl J Med. 2018 Jul 5;379(1):11-21. doi: 10.1056/NEJMoa1716153. N Engl J Med. 2018. PMID: 29972753 Free article. Clinical Trial.
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis.
Benson MD, Waddington-Cruz M, Berk JL, Polydefkis M, Dyck PJ, Wang AK, Planté-Bordeneuve V, Barroso FA, Merlini G, Obici L, Scheinberg M, Brannagan TH 3rd, Litchy WJ, Whelan C, Drachman BM, Adams D, Heitner SB, Conceição I, Schmidt HH, Vita G, Campistol JM, Gamez J, Gorevic PD, Gane E, Shah AM, Solomon SD, Monia BP, Hughes SG, Kwoh TJ, McEvoy BW, Jung SW, Baker BF, Ackermann EJ, Gertz MA, Coelho T. Benson MD, et al. Among authors: Brannagan TH. N Engl J Med. 2018 Jul 5;379(1):22-31. doi: 10.1056/NEJMoa1716793. N Engl J Med. 2018. PMID: 29972757 Free article. Clinical Trial.
Causes of neuropathy in patients referred as "idiopathic neuropathy".
Farhad K, Traub R, Ruzhansky KM, Brannagan TH 3rd. Farhad K, et al. Among authors: Brannagan TH. Muscle Nerve. 2016 Jun;53(6):856-61. doi: 10.1002/mus.24969. Epub 2015 Dec 29. Muscle Nerve. 2016. PMID: 26561790
Reply.
Farhad K, Brannagan TH 3rd. Farhad K, et al. Among authors: Brannagan TH. Muscle Nerve. 2017 Feb;55(2):291. doi: 10.1002/mus.25427. Epub 2016 Nov 4. Muscle Nerve. 2017. PMID: 27701749 No abstract available.
REPLY.
Farhad K, Brannagan TH 3rd. Farhad K, et al. Among authors: Brannagan TH. Muscle Nerve. 2016 Nov;54(5):983-984. doi: 10.1002/mus.25237. Epub 2016 Jul 17. Muscle Nerve. 2016. PMID: 27389826 No abstract available.
Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis.
Solomon SD, Adams D, Kristen A, Grogan M, González-Duarte A, Maurer MS, Merlini G, Damy T, Slama MS, Brannagan TH 3rd, Dispenzieri A, Berk JL, Shah AM, Garg P, Vaishnaw A, Karsten V, Chen J, Gollob J, Vest J, Suhr O. Solomon SD, et al. Among authors: Brannagan TH. Circulation. 2019 Jan 22;139(4):431-443. doi: 10.1161/CIRCULATIONAHA.118.035831. Circulation. 2019. PMID: 30586695 Clinical Trial.
Treatment of chronic inflammatory demyelinating polyneuropathy.
Kleyman I, Brannagan TH 3rd. Kleyman I, et al. Among authors: Brannagan TH. Curr Neurol Neurosci Rep. 2015 Jul;15(7):47. doi: 10.1007/s11910-015-0563-z. Curr Neurol Neurosci Rep. 2015. PMID: 26008811 Review.
Neuromuscular complications of hematopoietic stem cell transplantation.
Ruzhansky KM, Brannagan TH 3rd. Ruzhansky KM, et al. Among authors: Brannagan TH. Muscle Nerve. 2015 Oct;52(4):480-7. doi: 10.1002/mus.24724. Epub 2015 Aug 19. Muscle Nerve. 2015. PMID: 26044357 Review.
Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
Shije J, Brannagan TH 3rd. Shije J, et al. Among authors: Brannagan TH. Semin Neurol. 2019 Oct;39(5):596-607. doi: 10.1055/s-0039-1693008. Epub 2019 Oct 22. Semin Neurol. 2019. PMID: 31639843 Review.
73 results
Jump to page
Feedback